- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
WANG Deng, SUN Zhongying, GUO Qinglong, et al. Therapeutic effect and mechanism of the topical preparation of baicalein on atopic dermatitis[J]. J China Pharm Univ, 2025, 56(1): 99 − 109. DOI: 10.11665/j.issn.1000-5048.2024070302
|
To evaluate the therapeutic effect of baicalein topical preparation on atopic dermatitis, we first constructed two atopic dermatitis-like mouse models induced by calcipotriol and 1-fluoro-2,4-dinitrobenzene to assess their therapeutic effect with skin tissue staining and other experiments. It was found that topical preparation of baicalein could alleviate epidermal thickening of diseased skin tissues, repair damaged skin barrier proteins, and inhibit T helper 2 cells (Th2) infiltration and mast cell infiltration and activation in lesional sites. Cyberpharmacology was utilized to analyze whether baicalein could treat atopic dermatitis by interfering with multiple pathogenesis-associated pathways. Results indicated that baicalein reduced the mRNA levels of inflammatory factors and inhibited the phosphorylation of NF-κB p65 and STAT1 proteins in keratinocyte cells. Together, the topical preparation of baicalein may be effective in alleviating atopic dermatitis-like symptoms in mice by down-regulating the phosphorylation level of NF-κB in keratinocytes, thereby decreasing the expression of inflammatory factors in keratinocytes, which provides an idea and a theoretical basis for the topical preparation of baicalein for the treatment of inflammatory skin diseases such as atopic dermatitis.
| [1] |
Schuler CF 4th, Billi AC, Maverakis E, et al. Novel insights into atopic dermatitis[J]. J Allergy Clin Immunol, 2023, 151(5): 1145-1154. doi: 10.1016/j.jaci.2022.10.023
|
| [2] |
Atopic Dermatitis Working Group, Immunology Group, Chinese Society of Dermatology. Guideline for diagnosis and treatment of atopic dermatitis in China (2020)[J]. Chin J Dermatol(中华皮肤科杂志), 2020, 53(2): 81-88.
|
| [3] |
Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. management and treatment with phototherapy and systemic agents[J]. J Am Acad Dermatol, 2014, 71(2): 327-349. doi: 10.1016/j.jaad.2014.03.030
|
| [4] |
Kragstrup TW, Glintborg B, Svensson AL, et al. Waiting for JAK inhibitor safety data[J]. RMD Open, 2022, 8(1): e002236. doi: 10.1136/rmdopen-2022-002236
|
| [5] |
Rodrigues T, Reker D, Schneider P, et al. Counting on natural products for drug design[J]. Nat Chem, 2016, 8(6): 531-541. doi: 10.1038/nchem.2479
|
| [6] |
Zou R, Li J, Li JS. Research progress of drugs for the treatment of atopic dermatitis[J]. Chin J Pharmacoepidemiol (药物流行病学杂志), 2024, 33(4): 449-460.
|
| [7] |
Wang PW, Lin TY, Yang PM, et al. Therapeutic efficacy of Scutellaria baicalensis Georgi against psoriasis-like lesions via regulating the responses of keratinocyte and macrophage[J]. Biomedecine Pharmacother, 2022, 155: 113798. doi: 10.1016/j.biopha.2022.113798
|
| [8] |
Han SS, Huang KK, Chen CF, et al. Experience introduction of OUYANG Weiquan treating atopic dermatitis with classic prescriptions[J]. J New Chin Med (新中医), 2021, 53(9): 205-208.
|
| [9] |
Liu JX. Research on data mining and network pharmacology of eczema treated by traditional Chinese medicine based on clinical literature (基于临床类文献探究中医治疗湿疹的数据挖掘及网络药理学研究)[D]. Beijing: China Academy of Chinese Medical Sciences, 2022.
|
| [10] |
Meng YJ, Li NF, Zhai CY, et al. Study on effects and mechanism of Qingre Chushi Decoction on atopic dermatitis in NC/Nga mice[J]. China J Tradit Chin Med Pharm (中华中医药杂志), 2018, 33(5): 2056-2060.
|
| [11] |
Woźniak E, Owczarczyk-Saczonek A, Lange M, et al. The role of mast cells in the induction and maintenance of inflammation in selected skin diseases[J]. Int J Mol Sci, 2023, 24(8): 7021. doi: 10.3390/ijms24087021
|
| [12] |
Chu V, Ong PY. Constant vigilance! Managing threats to the skin barrier[J]. Ann Allergy Asthma Immunol, 2024, 132(6): 678-685. doi: 10.1016/j.anai.2024.02.004
|
| [13] |
James AE, Abdalgani M, Khoury P, et al. Th2-driven manifestations of inborn errors of immunity[J]. J Allergy Clin Immunol, 2024, 154(2): 245-254. doi: 10.1016/j.jaci.2024.05.007
|
| [14] |
Nedoszytko B, Sokołowska-Wojdyło M, Ruckemann-Dziurdzińska K, et al. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis[J]. Postepy Dermatol Alergol, 2014, 31(2): 84-91.
|
| [15] |
Kim J, Jung E, Yang W, et al. A novel multi-component formulation reduces inflammation in vitro and clinically lessens the symptoms of chronic eczematous skin[J]. Int J Mol Sci, 2023, 24(16): 12979. doi: 10.3390/ijms241612979
|
| [16] |
Catherine J, Roufosse F. What does elevated TARC/CCL17 expression tell us about eosinophilic disorders[J]? Semin Immunopathol, 2021, 43(3): 439-458. doi: 10.1007/s00281-021-00857-w
|
| [17] |
Zhang S, Fang XK, Xu BL, et al. Comprehensive analysis of phenotypes and transcriptome characteristics reveal the best atopic dermatitis mouse model induced by MC903[J]. J Dermatol Sci, 2024, 114(3): 104-114. doi: 10.1016/j.jdermsci.2024.05.003
|
| [18] |
Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases[J]. J Dermatol Sci, 2006, 43(2): 75-84. doi: 10.1016/j.jdermsci.2006.06.002
|
| [19] |
Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease[J]. Curr Allergy Asthma Rep, 2005, 5(4): 284-290. doi: 10.1007/s11882-005-0068-y
|
| [20] |
Lee H, Lee DH, Oh JH, et al. Skullcapflavone II suppresses TNF-α/IFN-γ-induced TARC, MDC, and CTSS production in HaCaT cells[J]. Int J Mol Sci, 2021, 22(12): 6428. doi: 10.3390/ijms22126428
|
| [21] |
Zheng XY, Zhang YH, Song WT, et al. Baicalin improves inflammatory response of human microglia by regulating cAMP-PKA-NF-κB/CREB pathway[J]. China J Chin Mater Med, 2023, 48(21): 5863-5870.
|
| [22] |
Huang IH, Chung WH, Wu PC, et al. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review[J]. Front Immunol, 2022, 13: 1068260. doi: 10.3389/fimmu.2022.1068260
|
| [23] |
Guo Q, Jin YZ, Chen XY, et al. NF-κB in biology and targeted therapy: new insights and translational implications[J]. Signal Transduct Target Ther, 2024, 9(1): 53. doi: 10.1038/s41392-024-01757-9
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：301748
DownLoad: